- Home
- APH vs TMO Comparison
APH vs TMO Comparison
Compare APH & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APH | TMO |
|---|---|---|
| Founded | 1932 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2B | 176.8B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | APH | TMO |
|---|---|---|
| Price | $147.24 | $531.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 19 |
| Target Price | $153.58 | ★ $637.61 |
| AVG Volume (30 Days) | ★ 7.6M | 1.6M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.67% | 0.33% |
| EPS Growth | ★ 73.96 | 7.32 |
| EPS | 3.34 | ★ 17.74 |
| Revenue | N/A | ★ $20,918,000,000.00 |
| Revenue This Year | $37.44 | $6.32 |
| Revenue Next Year | $12.21 | $5.12 |
| P/E Ratio | $44.56 | ★ $29.74 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $62.55 | $385.46 |
| 52 Week High | $167.13 | $643.99 |
Technical Indicators
Market Signals| Indicator | APH | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 65.61 |
| Support Level | $127.40 | $519.45 |
| Resistance Level | $154.05 | $549.44 |
| Average True Range (ATR) | 4.64 | 13.32 |
| MACD | 2.97 | 6.65 |
| Stochastic Oscillator | 93.36 | 95.90 |
Price Performance
Historical ComparisonAbout APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. It holds the second-largest connector market share globally and sells into the automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks end markets. Amphenol is diversified geographically, with operations in 40 countries.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).